Bimergen Energy (BESS) co-CEO and CFO awarded 100,000 stock options
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Bimergen Energy Corp director and Co-CEO/CFO Robert J. Brilon received a grant of 100,000 stock options for common stock. The options have an exercise price of $2.51 per share, were granted at no cost, and expire on 2036-04-30.
Following this award, Brilon directly holds derivative securities representing 510,002 underlying shares. This is a compensation-related grant reported as an acquisition, not an open-market purchase or sale of Bimergen Energy common stock.
Positive
- None.
Negative
- None.
Insider Trade Summary
1 transaction reported
Mixed
1 txn
Insider
BRILON ROBERT J
Role
Co CEO and CFO
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Options (Right to Buy) | 100,000 | $0.00 | -- |
Holdings After Transaction:
Options (Right to Buy) — 510,002 shares (Direct, null)
Footnotes (1)
Key Figures
Options granted: 100,000 options
Exercise price: $2.51 per share
Expiration date: 2036-04-30
+1 more
4 metrics
Options granted
100,000 options
Grant of options on 2026-04-30
Exercise price
$2.51 per share
Exercise price of granted options
Expiration date
2036-04-30
Options expiration date
Total derivatives after grant
510,002 underlying shares
Total derivative securities following transaction
Key Terms
Options (Right to Buy), exercise price, expiration date, derivative securities
4 terms
Options (Right to Buy) financial
"security_title: Options (Right to Buy)"
exercise price financial
"conversion_or_exercise_price: 2.5100"
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
expiration date financial
"expiration_date: 2036-04-30T00:00:00.000Z"
The expiration date is the deadline after which a financial contract, such as an option or a futures agreement, is no longer valid or can be exercised. It matters to investors because it determines the timeframe during which they can take action or benefit from the contract, similar to how a coupon or a food item has a limited period of usefulness. Once the expiration date passes, the contract loses its value or ability to be used.
derivative securities financial
"derivativeTransactionCount and total_shares_following_transaction fields"
Financial contracts whose value is tied to the price or performance of another asset, such as a stock, bond, commodity, index, or currency; examples include options, futures and swaps. They matter to investors because they let you protect against price swings, bet on future moves or gain larger exposure with less upfront cash—like using a lever or insurance policy on an investment—so they can amplify gains and losses and help manage portfolio risk.
FAQ
What did Bimergen Energy (BESS) disclose about Robert J. Brilon in this Form 4?
Bimergen Energy reported that director and Co-CEO/CFO Robert J. Brilon received a grant of 100,000 stock options. These options give the right to buy common stock at $2.51 per share and are a compensation-related award, not an open-market share purchase.
How many options were granted to the BESS Co-CEO/CFO and at what price?
Robert J. Brilon was granted 100,000 options to buy Bimergen Energy common stock. Each option has an exercise price of $2.51 per share, meaning he can choose to purchase shares at that fixed price if he exercises the options in the future.
When do Robert J. Brilon’s Bimergen Energy (BESS) options expire?
The granted options to Robert J. Brilon expire on 2036-04-30. He may choose to exercise the options any time before this expiration date, subject to any vesting or other terms not described in this summary of the Form 4 filing.
How many derivative securities does Robert J. Brilon hold after this BESS option grant?
After the reported transaction, Robert J. Brilon directly holds derivative securities covering 510,002 underlying shares. This total includes the newly granted 100,000 options and reflects his overall option-based exposure to Bimergen Energy common stock as reported in the Form 4 data.